While high-income nations have traditionally led in medical technology adoption, the Non-Alcoholic Steatohepatitis Biomarkers Market region of Asia-Pacific is currently experiencing the most rapid infrastructure development. Countries like India and China are seeing a surge in "lifestyle-related" liver diseases, leading to a massive push for affordable, mass-market diagnostic tools. This...